We really enjoyed day one of JCK Las Vegas💎
It's great to be back demonstrating the unique capabilities of #Opsydia Systems at Booth 54063.
We are hosting demonstrations throughout this year's event, so get in touch to book your slot: [email protected].
#JCKLasVegas#JCK2023
On @Arm’s decision to IPO in the US and the issue of funding later stage UK technology generally, I would suggest that the UK ecosystem is more risk averse than some of our competitors, writes Moray Wright, CEO of @ParkwalkAdvisor. https://t.co/BpljDYveeX
Fantastic to see portfolio co. @OpsydiaLtd have appointed Jimmy Gove as their Sales and Marketing Director 🎉
This new appointment launches a new phase for the diamond integrity specialists, allowing international expansion across both the diamond and coloured gemstones sectors.
How are these 3-university spin-outs looking to change lives?
We're excited to launch our next ‘Meet the Portfolio’ video series! 🎥
Feat. 3 of our portfolio co.’s from #MedTech & #DigitalHealth: @PetMedix @CharcoLtd & @Brainomix.
Watch below 👇
#InvestinginInnovation
Here's our CEO Andrew Rimmer and Head of Product, Lewis Fish walking across "St Mark's Square" to get to the JCK show! 😅
JCK Las Vegas is taking place at The Venetian, which means views like this on the commute!
Join us at Booth 54063 in the ‘Essentials and Tech’ area.
Delighted to announce the acquisition of portfolio co
@YASAMotors by @MercedesBenz
YASA, a spin-out from @UniofOxford are a pioneer in next-generation electric drive technology, manufacturing higher power density & higher torque e-motors & controllers
https://t.co/936Igrrrzx
We are pleased to announce the exit of our holding in @Inflowmatix, a technology leader in high-frequency water pressure data & analytics, who have been acquired by @suez We wish the management team continued success!
Read the PR here: https://t.co/RQRYGujbYw
"Mirriad’s technology is as complex as its concept is simple" @CityAM's @j_a_warrington discusses the power of in-content advertising with Mirriad CEO @StephanBeringer#MIRI https://t.co/2rHARBZk9k
Excited to announce our investment in @Mogrify_UK as part of total $33m Series A, second close led by Parkwalk. Mogrify, a Cambridge based cell therapy company will use funding to support advancement of #IO & #ophthalmology programs to IND-enabling studies https://t.co/vIAecXJgqK
Are you interested in investing in @imperialcollege technology whilst benefiting for income tax relief via EIS? Join us and @ParkwalkAdvisor for a webinar tomorrow to discuss the Imperial College Innovation Fund https://t.co/ScKTg4wpOv
Along with everyone else we applaud those who are doing so much in the battle against COVID-19. And we wanted to highlight some of the portfolio efforts in the fight against this virus.
#investingininnovation#EIS#universities#COVID19#wearetogether
https://t.co/Uq53FVX1TG
Professors from @imperialcollege have been instrumental in advising MPs on best course of action to take regarding COVID-19. EIS investors can now take advantage Imperial’s world leading R&D position
#investingininnovation#EIS#capitalatrisk#COVID19
https://t.co/OLqgHAHnKY
Never has the ability to monitor, react & predict behaviour of water networks been so critical. Especially doing it remotely & from home. We’ve a world class range of solutions to help the water industry, so get in touch. We are a remote first Company and we’re ready to help you.
Delighted to launch a new EIS Fund with @imperialcollege to invest in companies spun out of this global top ten university, allowing alumni / supporters of the College to support the commercial development of Imperial’s discoveries.
https://t.co/P1zELK5WL0
#EIS#CapitalAtRisk
A report from @ParkwalkAdvisor on #investment into university #tech spinouts and the need for innovative investment solutions to boost this sector further: https://t.co/K7zGE8h0Ns